TCL Archive Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML December 28, 2007
TCL Archive NCI Needs 100 SBIR Contracts By April 1 To Avoid Losing $5 Million; NIH Objects To DCT Comments March 22, 1985
TCL Archive Wyngaarden Helps Make Case For Facilities Funding, Reveals Plan For New NIH Building April 15, 1988
TCL Archive NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study. June 3, 2005
